Lung Cancers Enrolling by Invitation Phase 2 Trials for Ruxolitinib (DB08877)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02955940An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibTreatment